Simplifying Intravenous TNF-Alpha Inhibitor TherapyDiplomat supports patients with personalized care.
Diplomat Specialty Infusion Group supports patients nationwide who receive intravenous inhibitors of tumor necrosis factor (TNF)-alpha for inflammatory conditions. Our support covers ulcerative colitis, rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, plaque psoriasis, and more. Inhibitors we dispense include Remicade® (infliximab), Simponi Aria® (golimumab), and biosimilars of infliximab.
Diplomat offers 24/7 clinical pharmacist access and home administration of TNF-alpha inhibitors. We also help patients meet insurance requirements and seek third-party financial assistance on their behalf. We do whatever it takes to help patients manage therapy.
For drug information, click here.
Upcoming TreatmentsWe keep you informed about new specialty medications.
Diplomat actively monitors specialty medications in the government's review and approval process. You can search our database to see if there will be new treatment options for your condition you can discuss with your doctor.
ResourcesDiplomat connects you with the support you need. We do much more than just fill your prescriptions. Diplomat Specialty Infusion Group provides a number of resources to support you throughout treatment.
How can Diplomat help me?We’ll answer your questions about Diplomat Specialty Infusion Group.
TALK WITH US
Financial AssistanceWe’ll look for ways to help you afford therapy.
There are many ways to get help paying for specialty medications. We'll seek third-party programs and support the application process from start to finish.